Brind.

Boston Scientific and J&J face charges due to Trump's trade strategy, while Stryker and Boston Scientific complete major acquisitions in the medtech sector.

1 report, 0 independent Updated Jul 9

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Stryker Corporation Johnson & Johnson Boston Scientific

Keep exploring

The entities involved

Stryker Corporation
American medical technologies company
- Kevin A. Lobo was appointed as the Chair and CEO of Stryker Corporation.Sat 12:46
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
- Johnson & Johnson and Mastercard are currently top holdings within the JEPI investment fund.04:13
- Johnson & Johnson and Broadcom are noted as major holdings in the same investment fund, which also involves Apollo Global Management.03:10
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
- Boston Scientific introduced DCBs to the U.S. market on October 21, 2026.Wed 17:38

Coverage

Newest first; wire copies grouped

Jul 9Unknown outlet